Drug Eruptions from Mesna: After Cyclophosphamide Treatment of Patients with Systemic Lupus Erythematosus and Dermatomyositis

Archives of Dermatology

Volumn 128, Issue 1, 1992, Pages 80-82

  Zonzits, Eva ^a   Aberer, Werner ^a   Tappeiner, Gerhard ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DIMENHYDRINATE; MESNA; METHYLPREDNISOLONE; METOCLOPRAMIDE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOMYOSITIS; DRUG ERUPTION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; BIOPSY; CASE REPORT; CYCLOPHOSPHAMIDE; DERMATOMYOSITIS; DRUG ERUPTIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MESNA; METHYLPREDNISOLONE; METOCLOPRAMIDE; MIDDLE AGE; PATCH TESTS; SKIN;

EID: 85047690250     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.128.1.80     Document Type: Article

References (7)

1. 1. Lang E, Goos M. Hypersensitivity to mesna. Lancet. 1985; 2: 329.
2. 2. Frosch PJ, Weickel R. Allergie vom Soforttyp nach Mesna. Dtsch Med Wochenschr. 1986; 49: 1901-1902.
3. 3. Austin HA, Klippel JH, Balow JE, et al. Therapy of lupus nephritis. N Engl J Med. 1986; 314: 614-619.
4. 4. Fisher AA. The role of patch testing. In: Fisher AA, ed. Contact Dermatitis. 3rd ed. Philadelphia, Pa: Lea & Febiger; 1986: 9-29.
5. 5. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982; 25: 1271-1277.
6. 6. Rappersberger K, Tschachler E, Tani M, Wolff K. Bullous disease in systemic lupus erythematosus. J Am Acad Dermatol. 1989; 21: 745-752.
7. 7. Korkij W, Soltani K. Fixed drug eruption: a brief review. Arch Dermatol. 1984; 120: 520-524.